Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

Presentation TCT 2025

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Presenter: Gerald S. Werner

October 25, 2025

News Daily News

Long-term CTO Data Raise Questions Over Primary Goals of Care

Yael L. Maxwell

February 08, 2021

News Daily News

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

Todd Neale

September 22, 2020

News Conference News TCT 2019

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Yael L. Maxwell

September 29, 2019

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

Presentation TCT 2018

Data Analysis: The Big Three Trials - Decision CTO, EURO CTO, OPEN CTO

Presenter: John A. Spertus, Robert W. Yeh, Ajay J. Kirtane

September 24, 2018

Presentation TCTAP 2018

DECISION-CTO: Updated QOL and Long-Term Outcomes

Presenter: Seung-Whan Lee

April 28, 2018

News Conference News SCAI 2018

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

L.A. McKeown

April 26, 2018

Presentation CTO 2018

Decision CTO, EURO CTO, OPEN CTO

Presenter: Gregg W. Stone, Ajay J. Kirtane

February 16, 2018

Presentation TTT 2018

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

Presenter: Alfredo R. Galassi

January 14, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Emmanouil S. Brilakis

November 01, 2017

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Presenter: David J. Cohen, Ajay J. Kirtane, Gerald S. Werner

November 01, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From DECISION-CTO

Presenter: Barry D. Rutherford, Robert W. Yeh, Seung-Whan Lee

October 31, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Todd Neale

October 31, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

News Conference News EuroPCR 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Yael L. Maxwell

May 18, 2017

News Daily News

Another Observational CTO Study Confirms Procedural Success of PCI but Doesn't Definitively Show Effect on Outcomes

Yael L. Maxwell

May 05, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yael L. Maxwell

April 17, 2017

Advertisement

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Long-term CTO Data Raise Questions Over Primary Goals of Care

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Data Analysis: The Big Three Trials - Decision CTO, EURO CTO, OPEN CTO

DECISION-CTO: Updated QOL and Long-Term Outcomes

PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI

Decision CTO, EURO CTO, OPEN CTO

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

The Biggest News of 2017: TCTMD’s Top 10

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Outcomes and Clinical Implications From DECISION-CTO

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Another Observational CTO Study Confirms Procedural Success of PCI but Doesn't Definitively Show Effect on Outcomes

TCTMD’s Top 10 Most Popular Stories for April 2017

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content